May 30
|
Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
|
May 14
|
Apyx Medical First Quarter 2025 Earnings: EPS Beats Expectations
|
May 13
|
Apyx Medical wins FDA clearance for body contouring tech
|
May 13
|
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
|
May 11
|
Apyx Medical Corporation (NASDAQ:APYX) Analysts Are Pretty Bullish On The Stock After Recent Results
|
May 9
|
Apyx Medical Corp (APYX) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
|
May 8
|
Apyx: Q1 Earnings Snapshot
|
May 8
|
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
|
May 1
|
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence
|
Apr 29
|
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
|
Jan 13
|
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2024 Revenue Results
|
Oct 3
|
Apyx (APYX) Upgraded to Buy: Here's What You Should Know
|
Jul 25
|
At US$1.39, Is It Time To Put Apyx Medical Corporation (NASDAQ:APYX) On Your Watch List?
|
Jul 25
|
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
|
Jun 26
|
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
|
May 13
|
Apyx Medical Corporation (NASDAQ:APYX) Q1 2024 Earnings Call Transcript
|
May 12
|
Analysts Have Been Trimming Their Apyx Medical Corporation (NASDAQ:APYX) Price Target After Its Latest Report
|
May 11
|
Apyx Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
May 9
|
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
|
May 9
|
Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
|